search
Back to results

Evaluation of a "Fast Track" Respiratory Therapy Clinic for Patients With Suspected Severe Sleep-Disordered Breathing

Primary Purpose

Sleep Disordered Breathing

Status
Unknown status
Phase
Not Applicable
Locations
Canada
Study Type
Interventional
Intervention
Fast Track
Sponsored by
University of Calgary
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional health services research trial for Sleep Disordered Breathing

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • referred to the FMC Sleep Centre for assessment of SDB
  • meet one of the three criteria for suspected severe SDB:

    1. Respiratory disturbance index (RDI) >/= 30 events/hour on an ambulatory sleep test
    2. Mean nocturnal oxygen saturation </= 85% on an ambulatory sleep test
    3. Suspected hypoventilation, defined by an RDI >/= 15 events/hour on an ambulatory sleep test and partial pressure of carbon dioxide >/= 45 mmHg on arterial blood gas
    4. On supplemental oxygen therapy with high suspicion of SDB (as determined by physician review of referral)

Exclusion Criteria:

  • Suspected concomitant sleep disorder other than SDB
  • A previous diagnosis of OSA treated with PAP or dental appliance
  • Primary health insurance provided by a province other than Alberta
  • Failure to provide consent to participate in the study
  • Under the age of 18

Sites / Locations

  • Foothills Medical Centre Sleep Centre

Arms of the Study

Arm 1

Arm 2

Arm Type

No Intervention

Active Comparator

Arm Label

Standard Management

Fast Track

Arm Description

Patients in the "Standard Management" arm will be assessed without any interventions.Patients will be assessed by a sleep respirologist and follow a management plan that is determined by the sleep physician and patient. This plan may involve polysomnography or the initiation of PAP therapy. If further testing is ordered, follow-up may occur with the physician or with an ACP, at the physician's discretion. For patients initiating PAP therapy, the decision to delegate follow-up to an ACP will be left up to the physician, as the intent of this study is to observe real-world practice and not to change the management of individual patients.

In the "Fast Track" arm, an ACP will perform the initial assessment and will determine the management plan with the patient.

Outcomes

Primary Outcome Measures

Adherence to positive airway pressure (PAP) therapy
Data includes number of days of PAP use and number of hours used per day.

Secondary Outcome Measures

Change in daytime sleepiness
Epworth Sleepiness Scale
Health care utilization
Combination of physician visits, emergency department visits, hospitalizations
Incremental cost-effectiveness ratio
Comparing cost/QALY for intervention vs. control arm (QALY determined from Health Utilities Index
Time from date of referral to date of treatment initiation
Comparing cycle times for intervention vs. control arm
Change in daytime sleepiness
Epworth Sleepiness Scale
Adherence to positive airway pressure (PAP) therapy
Data includes number of days of PAP use and number of hours used per day.
Change in disease specific health-related quality of life
Sleep Apnea Quality of Life Index
Change in disease specific health-related quality of life
Sleep Apnea Quality of Life Index
Patient experience
Visit-Specific Instrument (VSQ-9)
Patient experience
Visit-Specific Instrument (VSQ-9)
Number of sleep diagnostic tests and sleep ambulatory care visits
Will measure sleep physician and ACP visits as well as polysomnography and ambulatory testing
Change in severity of sleep-disordered breathing
Respiratory disturbance index from ambulatory testing
Change in severity of sleep-disordered breathing
Respiratory disturbance index from ambulatory testing
Change in general health-related quality of life
Health Utilities Index
Change in general health-related quality of life
Health Utilities Index

Full Information

First Posted
July 13, 2014
Last Updated
March 30, 2020
Sponsor
University of Calgary
Collaborators
The Lung Association
search

1. Study Identification

Unique Protocol Identification Number
NCT02191085
Brief Title
Evaluation of a "Fast Track" Respiratory Therapy Clinic for Patients With Suspected Severe Sleep-Disordered Breathing
Official Title
Evaluation of a "Fast Track" Respiratory Therapy Clinic for Patients With Suspected Severe Sleep-Disordered Breathing
Study Type
Interventional

2. Study Status

Record Verification Date
March 2020
Overall Recruitment Status
Unknown status
Study Start Date
October 2014 (Actual)
Primary Completion Date
December 2020 (Anticipated)
Study Completion Date
December 2020 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
University of Calgary
Collaborators
The Lung Association

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
Access to medical care for patients with breathing disorders during sleep is a major problem for Canadians. Recently, there has been increasing interest in how health care providers who are not physicians can help to improve access to medical care for these patients, but it is unclear whether patients with severe sleep-disordered breathing who receive care from these non-physician providers have the same response to treatment as patients who receive care from physicians. Since these severe have a high risk of developing cardiac and respiratory complications and of being hospitalized, an initiative to improve access such as the use of non-physician providers could be of great benefit to individual patients and the health care system. The objectives of this project are: to determine whether patients with severe breathing disorders during sleep have the same response to treatment when cared for by non-physician health care providers (respiratory therapists) as they do when cared for by physicians; to determine the effects of non-physician health care provider treatment to patient access; to determine health care utilization and related costs associated with non-physician health care provider treatment.
Detailed Description
The difficulty in providing timely access to sleep specialists is widespread. These delays are particularly important for patients with severe SDB due to the increased risk of adverse clinical outcomes and potential associated healthcare costs. The lack of timely access has sparked an interest in the use of alternate care providers (ACPs) to manage patients with SDB. Our group and others have demonstrated that ACPs are an effective and efficient substitute for physicians for patients with uncomplicated SDB. However, the role of ACPs in the management of patients with severe SDB remains unclear. Prompted by wait times that far exceed current Canadian guidelines, we have recently implemented an ACP-led "Fast Track" clinic for patients who are referred to the Foothills Medical Centre (FMC) Sleep Centre with suspected severe SDB. In this clinic, patients with suspected severe SDB are assessed by a sleep-trained registered respiratory therapist functioning as an ACP. Decisions regarding further sleep testing and treatment are made by the patient and ACP, under the guidance of a sleep physician. This model of care differs from a physician-led model that is used at the FMC Sleep Centre. To evaluate this novel care delivery model, we have designed a randomized trial comparing outcomes for patients in the "Fast Track" clinic to those who undergo conventional, physician-led care. The specific goals of this study are: to compare the clinical effectiveness of an ACP-led clinic for patients with suspected severe SDB to physician-led management; to determine whether cycle times from referral to diagnosis and treatment for patients referred with suspected severe SDB can be reduced by an ACP-led clinic; to determine the impact of an ACP-led clinic on the demand for sleep physicians, ACPs and diagnostic testing; to compare the cost-effectiveness of these models of care using data on healthcare utilization, costs, and patient reported health-related quality of life (HRQOL). Patients in the "Standard Management" arm will be assessed by a sleep respirologist and follow a management plan that is determined by the sleep physician and patient. This plan may involve polysomnography or the initiation of PAP therapy. If further testing is ordered, follow-up may occur with the physician or with an ACP, at the physician's discretion. For patients initiating PAP therapy, the decision to delegate follow-up to an ACP will be left up to the physician, as the intent of this study is to observe real-world practice and not to change the management of individual patients. In the "Fast Track" arm, an ACP will perform the initial assessment and will determine the management plan with the patient. To ensure patient safety, the management plan will be discussed with a sleep respirologist, who will be designated as the patient's primary sleep physician. This sleep physician will be available at the FMC Sleep Centre during the "Fast Track" clinic to assist with the assessment of patients who appear unwell (e.g. severe hypoxemia, decompensated cardiorespiratory failure, etc.). As in the "Standard Management" arm, follow-up visits to review test results, discuss and initiate treatment, or to assess treatment response may occur with the ACP who performed the initial assessment or may be delegated to any other ACP. As is usual procedure at the FMC Sleep Centre, ambulatory sleep test requisitions will be completed by ACPs or physicians, whereas all polysomnogram requisitions will be completed by the primary sleep physician to ensure adequate blinding of patient assignment. The research associate will ensure that all tests are interpreted in advance of clinic visits. Patients who are followed by ACPs in either arm can be referred to the primary sleep physician for assessment of non-respiratory sleep disorders, or for persistent symptoms such as daytime sleepiness.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Sleep Disordered Breathing

7. Study Design

Primary Purpose
Health Services Research
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Care Provider
Allocation
Randomized
Enrollment
164 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Standard Management
Arm Type
No Intervention
Arm Description
Patients in the "Standard Management" arm will be assessed without any interventions.Patients will be assessed by a sleep respirologist and follow a management plan that is determined by the sleep physician and patient. This plan may involve polysomnography or the initiation of PAP therapy. If further testing is ordered, follow-up may occur with the physician or with an ACP, at the physician's discretion. For patients initiating PAP therapy, the decision to delegate follow-up to an ACP will be left up to the physician, as the intent of this study is to observe real-world practice and not to change the management of individual patients.
Arm Title
Fast Track
Arm Type
Active Comparator
Arm Description
In the "Fast Track" arm, an ACP will perform the initial assessment and will determine the management plan with the patient.
Intervention Type
Procedure
Intervention Name(s)
Fast Track
Intervention Description
In the "Fast Track" arm, an ACP will perform the initial assessment and will determine the management plan with the patient. To ensure patient safety, the management plan will be discussed with a sleep respirologist, who will be designated as the patient's primary sleep physician. This sleep physician will be available at the FMC Sleep Centre during the "Fast Track" clinic to assist with the assessment of patients who appear unwell. As in the "Standard Management" arm, follow-up visits to review test results, discuss and initiate treatment, or to assess treatment response may occur with the ACP who performed the initial assessment or may be delegated to any other ACP.
Primary Outcome Measure Information:
Title
Adherence to positive airway pressure (PAP) therapy
Description
Data includes number of days of PAP use and number of hours used per day.
Time Frame
3 months after treatment initiation
Secondary Outcome Measure Information:
Title
Change in daytime sleepiness
Description
Epworth Sleepiness Scale
Time Frame
3 months after treatment initiation
Title
Health care utilization
Description
Combination of physician visits, emergency department visits, hospitalizations
Time Frame
1 year after treatment initiation
Title
Incremental cost-effectiveness ratio
Description
Comparing cost/QALY for intervention vs. control arm (QALY determined from Health Utilities Index
Time Frame
1 year after treatment initiation
Title
Time from date of referral to date of treatment initiation
Description
Comparing cycle times for intervention vs. control arm
Time Frame
Expected within 1 year (unknown due to nature of outcome)
Title
Change in daytime sleepiness
Description
Epworth Sleepiness Scale
Time Frame
1 year after treatment initiation
Title
Adherence to positive airway pressure (PAP) therapy
Description
Data includes number of days of PAP use and number of hours used per day.
Time Frame
1 year after treatment initiation
Title
Change in disease specific health-related quality of life
Description
Sleep Apnea Quality of Life Index
Time Frame
3 months after treatment initiation
Title
Change in disease specific health-related quality of life
Description
Sleep Apnea Quality of Life Index
Time Frame
1 year after treatment initiation
Title
Patient experience
Description
Visit-Specific Instrument (VSQ-9)
Time Frame
3 months after treatment initiation
Title
Patient experience
Description
Visit-Specific Instrument (VSQ-9)
Time Frame
1 year after treatment initiation
Title
Number of sleep diagnostic tests and sleep ambulatory care visits
Description
Will measure sleep physician and ACP visits as well as polysomnography and ambulatory testing
Time Frame
1 year after treatment initiation
Title
Change in severity of sleep-disordered breathing
Description
Respiratory disturbance index from ambulatory testing
Time Frame
3 months after treatment initiation
Title
Change in severity of sleep-disordered breathing
Description
Respiratory disturbance index from ambulatory testing
Time Frame
1 year after treatment initiation
Title
Change in general health-related quality of life
Description
Health Utilities Index
Time Frame
3 months after treatment initiation
Title
Change in general health-related quality of life
Description
Health Utilities Index
Time Frame
1 year after treatment initiation

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: referred to the FMC Sleep Centre for assessment of SDB meet one of the three criteria for suspected severe SDB: Respiratory disturbance index (RDI) >/= 30 events/hour on an ambulatory sleep test Mean nocturnal oxygen saturation </= 85% on an ambulatory sleep test Suspected hypoventilation, defined by an RDI >/= 15 events/hour on an ambulatory sleep test and partial pressure of carbon dioxide >/= 45 mmHg on arterial blood gas On supplemental oxygen therapy with high suspicion of SDB (as determined by physician review of referral) Exclusion Criteria: Suspected concomitant sleep disorder other than SDB A previous diagnosis of OSA treated with PAP or dental appliance Primary health insurance provided by a province other than Alberta Failure to provide consent to participate in the study Under the age of 18
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Sachin R Pendharkar, MD, MSc
Organizational Affiliation
University of Calgary
Official's Role
Principal Investigator
Facility Information:
Facility Name
Foothills Medical Centre Sleep Centre
City
Calgary
State/Province
Alberta
ZIP/Postal Code
T2N 2T9
Country
Canada

12. IPD Sharing Statement

Plan to Share IPD
Undecided
Citations:
PubMed Identifier
15781100
Citation
Marin JM, Carrizo SJ, Vicente E, Agusti AG. Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study. Lancet. 2005 Mar 19-25;365(9464):1046-53. doi: 10.1016/S0140-6736(05)71141-7.
Results Reference
background
PubMed Identifier
16282178
Citation
Yaggi HK, Concato J, Kernan WN, Lichtman JH, Brass LM, Mohsenin V. Obstructive sleep apnea as a risk factor for stroke and death. N Engl J Med. 2005 Nov 10;353(19):2034-41. doi: 10.1056/NEJMoa043104.
Results Reference
background
PubMed Identifier
10805822
Citation
Peppard PE, Young T, Palta M, Skatrud J. Prospective study of the association between sleep-disordered breathing and hypertension. N Engl J Med. 2000 May 11;342(19):1378-84. doi: 10.1056/NEJM200005113421901.
Results Reference
background
PubMed Identifier
9042067
Citation
Flemons WW, Tsai W. Quality of life consequences of sleep-disordered breathing. J Allergy Clin Immunol. 1997 Feb;99(2):S750-6. doi: 10.1016/s0091-6749(97)70123-4.
Results Reference
background
PubMed Identifier
14505600
Citation
Reimer MA, Flemons WW. Quality of life in sleep disorders. Sleep Med Rev. 2003 Aug;7(4):335-49. doi: 10.1053/smrv.2001.0220.
Results Reference
background
PubMed Identifier
11502632
Citation
Berg G, Delaive K, Manfreda J, Walld R, Kryger MH. The use of health-care resources in obesity-hypoventilation syndrome. Chest. 2001 Aug;120(2):377-83. doi: 10.1378/chest.120.2.377.
Results Reference
background
PubMed Identifier
20339144
Citation
Redline S, Yenokyan G, Gottlieb DJ, Shahar E, O'Connor GT, Resnick HE, Diener-West M, Sanders MH, Wolf PA, Geraghty EM, Ali T, Lebowitz M, Punjabi NM. Obstructive sleep apnea-hypopnea and incident stroke: the sleep heart health study. Am J Respir Crit Care Med. 2010 Jul 15;182(2):269-77. doi: 10.1164/rccm.200911-1746OC. Epub 2010 Mar 25.
Results Reference
background
PubMed Identifier
19136368
Citation
Antic NA, Buchan C, Esterman A, Hensley M, Naughton MT, Rowland S, Williamson B, Windler S, Eckermann S, McEvoy RD. A randomized controlled trial of nurse-led care for symptomatic moderate-severe obstructive sleep apnea. Am J Respir Crit Care Med. 2009 Mar 15;179(6):501-8. doi: 10.1164/rccm.200810-1558OC. Epub 2009 Jan 8.
Results Reference
background
PubMed Identifier
32310283
Citation
Thornton CS, Tsai WH, Santana MJ, Penz ED, Flemons WW, Fraser KL, Hanly PJ, Pendharkar SR. Effects of Wait Times on Treatment Adherence and Clinical Outcomes in Patients With Severe Sleep-Disordered Breathing: A Secondary Analysis of a Noninferiority Randomized Clinical Trial. JAMA Netw Open. 2020 Apr 1;3(4):e203088. doi: 10.1001/jamanetworkopen.2020.3088.
Results Reference
derived
PubMed Identifier
31437008
Citation
Pendharkar SR, Tsai WH, Penz ED, Santana MJ, Ip-Buting A, Kelly J, Flemons WW, Fraser KL, Hanly PJ. A Randomized Controlled Trial of an Alternative Care Provider Clinic for Severe Sleep-disordered Breathing. Ann Am Thorac Soc. 2019 Dec;16(12):1558-1566. doi: 10.1513/AnnalsATS.201901-087OC.
Results Reference
derived
PubMed Identifier
28360244
Citation
Ip-Buting A, Kelly J, Santana MJ, Penz ED, Flemons WW, Tsai WH, Fraser KL, Hanly PJ, Pendharkar SR. Evaluation of an alternative care provider clinic for severe sleep-disordered breathing: a study protocol for a randomised controlled trial. BMJ Open. 2017 Mar 29;7(3):e014012. doi: 10.1136/bmjopen-2016-014012.
Results Reference
derived

Learn more about this trial

Evaluation of a "Fast Track" Respiratory Therapy Clinic for Patients With Suspected Severe Sleep-Disordered Breathing

We'll reach out to this number within 24 hrs